1. Home
  2. CSTE vs FEMY Comparison

CSTE vs FEMY Comparison

Compare CSTE & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.57

Market Cap

61.9M

Sector

Industrials

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.87

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
FEMY
Founded
1987
2004
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.9M
51.5M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
CSTE
FEMY
Price
$1.57
$0.87
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$6.83
AVG Volume (30 Days)
511.2K
1.9M
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$400,656,000.00
$2,061,502.00
Revenue This Year
N/A
$64.02
Revenue Next Year
$1.59
$147.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
63.53
52 Week Low
$0.86
$0.31
52 Week High
$5.04
$1.80

Technical Indicators

Market Signals
Indicator
CSTE
FEMY
Relative Strength Index (RSI) 55.28 51.24
Support Level $0.86 $0.79
Resistance Level $1.95 $0.91
Average True Range (ATR) 0.21 0.07
MACD 0.03 -0.02
Stochastic Oscillator 64.49 26.06

Price Performance

Historical Comparison
CSTE
FEMY

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: